Biotechnology Market Size, Share, Analysis Report

Biotechnology Market Size by Application (Biopharmacy, Bioindustries, Bioservices, Bioagriculture, Bioinformatics), By Technology (Fermentation, Tissue engineering and regeneration, PCR Technology, Nanobiotechnology, Chromatography, DNA sequencing, Cell Based Assay), By Region (North America, Europe, Asia-Pacific, Rest of the World), Market Analysis Report, Forecast

Biotechnology is an interdisciplinary, innovative field that uses living biological systems, or derivatives, organisms to outcomes and change or develop processes for creating healthcare-related therapeutics and products.

Purchase User License

MARKET SNAPSHOT

Major Players

  • AstraZeneca
  • Gilead Sciences, Inc
  • CELGENE CORPORATION
  • Biogen
  • Abbott
  • Study period:

    2023-2028

    Base Year:

    2022

    CAGR:

    5

    Fastest Growing Market:

    APAC

    Largest Market:

    North America

    REPORT DESCRIPTION

    Biotechnology is an interdisciplinary, innovative field that uses living biological systems, or derivatives, organisms to outcomes and change or develop processes for creating healthcare-related therapeutics and products. It has profound influence on different sectors such as production of food & chemicals, medicine & pharmaceuticals, genomics, and others. It has completed and important use in solving dangerous challenges related to food & energy supply, health & well-being, and environmental protection. The rising prevalence of chronic disorders has increased the requirement for drug discovery, which in turn has resulted in the market development of the biotechnology market. The biotechnology drug discovery process is majorly mandatory for diseases such as asthma, hypertension, heart stroke, cancer, etc. The growth in demand for therapeutics solutions and diagnostics for these chronic diseases is fuelling market development. Therefore, biotechnology has verified to be useful in improving filling up and healthcare access the medical requirements in certain regions. The improved usage of biotechnology in agriculture due to the rising demand for organic food products is also contributing to the market development.

    The global Biotechnology market is segregated on the basis of Application as Biopharmacy, Bioindustries, Bioservices, Bioagriculture, and Bioinformatics. Based on Technology the global Biotechnology market is segmented in Fermentation, Tissue engineering and regeneration, PCR Technology, Nanobiotechnology, Chromatography, DNA sequencing, Cell Based Assay, and Others.

    The global Biotechnology market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Biotechnology market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.

    Competitive Rivalry

    AstraZeneca, Gilead Sciences, Inc, CELGENE CORPORATION, Biogen, Abbott, Amgen Inc., Novo Nordisk A/S, Merck & Co., Johnson & Johnson Services, Inc., Novartis AG, Sanofi, F. Hoffmann-La Roche Ltd., Pfizer, Inc., Lonza, and others are among the major players in the global Biotechnology market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.

    The Biotechnology Market has been segmented as below:

    Biotechnology Market, By Application

    • Biopharmacy
    • Bioindustries
    • Bioservices
    • Bioagriculture
    • Bioinformatics

    Biotechnology Market, By Technology

    • Fermentation
    • Tissue engineering and regeneration
    • PCR Technology
    • Nanobiotechnology
    • Chromatography
    • DNA sequencing
    • Cell Based Assay
    • Others

    Biotechnology Market, By Region

    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World

    Biotechnology Market, By Company

    • AstraZeneca
    • Gilead Sciences, Inc.
    • CELGENE CORPORATION
    • Biogen
    • Abbott
    • Amgen Inc.
    • Novo Nordisk A/S
    • Merck & Co.
    • Johnson & Johnson Services, Inc.
    • Novartis AG
    • Sanofi
    • F. Hoffmann-La Roche Ltd.
    • Pfizer, Inc.
    • Lonza

    The report covers:

    • Global Biotechnology market sizes from 2021 to 2028, along with CAGR for 2023-2028
    • Market size comparison for 2022 vs 2028, with actual data for 2022, estimates for 2023 and forecast from 2024 to 2028
    • Global Biotechnology market trends, covering comprehensive range of consumer trends & manufacturer trends
    • Value chain analysis covering participants from raw material suppliers to the downstream buyer in the global Biotechnology market
    • Major market opportunities and challenges in forecast timeframe to be focused
    • Competitive landscape with analysis on competition pattern, portfolio comparisons, development trends and strategic management
    • Comprehensive company profiles of the key industry players

    Report Scope:

    The global Biotechnology market report scope includes detailed study covering underlying factors influencing the industry trends. The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Biotechnology market share. Major industry players with significant revenue share include AstraZeneca, Gilead Sciences, Inc., CELGENE CORPORATION, Biogen, Abbott, Amgen Inc., Novo Nordisk A/S, Merck & Co., Johnson & Johnson Services, Inc., Novartis AG, Sanofi, F. Hoffmann-La Roche Ltd., Pfizer, Inc., Lonza, and others.

    Reasons to Buy this Report:

    • Gain detailed insights on the Biotechnology industry trends
    • Find complete analysis on the market status
    • Identify the Biotechnology market opportunities and growth segments
    • Analyse competitive dynamics by evaluating business segments & product portfolios
    • Facilitate strategy planning and industry dynamics to enhance decision making

    Customization

    Customized report as per the requirement can be offered with appropriate recommendations.

    Below are our New Reports :-

    Feed Phytogenics Market

    Cardiac Biomarkers market

    Cell-based Assays market

    Bioburden Testing Market

    Biologics Development and Manufacturing Testing market

    1.    Introduction

    1.1.    Key Points
    1.2.    Report Description
    1.3.    Markets Covered
    1.4.    Stakeholders

    2.    Research Methodology

    2.1.    Research Scope
    2.2.    Research Methodology
    2.2.1.    Market Research Process
    2.2.2.    Research Methodology
    2.2.2.1.    Secondary Research
    2.2.2.2.    Primary Research
    2.2.2.3.    Models for Estimation
    2.3.    Market Size Estimation
    2.3.1.    Bottom-Up Approach
    2.3.2.    Top-Down Approach

    3.    Executive Summary

    4.    Market Overview

    4.1.    Introduction
    4.2.    Drivers
    4.3.    Restraints
    4.4.    Opportunities
    4.5.    Challenges

    5.    Biotechnology Market, By Technology

    5.1.    Key Points
    5.2.    Fermentation
    5.3.    Tissue engineering and regeneration
    5.4.    PCR Technology
    5.5.    Nanobiotechnology
    5.6.    Chromatography
    5.7.    DNA sequencing
    5.8.    Cell Based Assay
    5.9.    Others

    6.    Biotechnology Market, By Application

    6.1.    Key Points
    6.2.    Biopharmacy
    6.3.    Bioindustries
    6.4.    Bioservices
    6.5.    Bioagriculture
    6.6.    Bioinformatics

    7.    Competitive Landscape

    7.1.    Introduction
    7.2.    Recent Developments
    7.2.1.    Mergers & Acquisitions
    7.2.2.    New Product Developments
    7.2.3.    Portfolio/Production Capacity Expansions
    7.2.4.    Joint Ventures, Collaborations, Partnerships & Agreements
    7.2.5.    Others

    8.    Company Profiles

    8.1 AstraZeneca
    8.1.1 Company Overview
    8.1.2 Product/Service Landscape
    8.1.3 Financial Overview
    8.1.4 Recent Developments
    8.2 Young Living Biotechnology
    8.2.1 Company Overview
    8.2.2 Product/Service Landscape
    8.2.3 Financial Overview
    8.2.4 Recent Developments
    8.3 CELGENE CORPORATION
    8.3.1 Company Overview
    8.3.2 Product/Service Landscape
    8.3.3 Financial Overview
    8.3.4 Recent Developments
    8.4 Biogen
    8.4.1 Company Overview
    8.4.2 Product/Service Landscape
    8.4.3 Financial Overview
    8.4.4 Recent Developments
    8.5 Abbott
    8.5.1 Company Overview
    8.5.2 Product/Service Landscape
    8.5.3 Financial Overview
    8.5.4 Recent Developments
    8.6 Amgen Inc.
    8.6.1 Company Overview
    8.6.2 Product/Service Landscape
    8.6.3 Financial Overview
    8.6.4 Recent Developments
    8.7 Novo Nordisk A/S
    8.7.1 Company Overview
    8.7.2 Product/Service Landscape
    8.7.3 Financial Overview
    8.7.4 Recent Developments
    8.8 Merck & Co.
    8.8.1 Company Overview
    8.8.2 Product/Service Landscape
    8.8.3 Financial Overview
    8.8.4 Recent Developments
    8.8 Johnson & Johnson Services, Inc.
    8.8.1 Company Overview
    8.8.2 Product/Service Landscape
    8.8.3 Financial Overview
    8.8.4 Recent Developments
    8.10 Novartis AG
    8.10.1 Company Overview
    8.10.2 Product/Service Landscape
    8.10.3 Financial Overview
    8.10.4 Recent Developments
    8.11 Sanofi
    8.11.1 Company Overview
    8.11.2 Product/Service Landscape
    8.11.3 Financial Overview
    8.11.4 Recent Developments
    8.12 F. Hoffmann-La Roche Ltd.
    8.12.1 Company Overview
    8.12.2 Product/Service Landscape
    8.12.3 Financial Overview
    8.12.4 Recent Developments
    8.13 Pfizer, Inc.
    8.13.1 Company Overview
    8.13.2 Product/Service Landscape
    8.13.3 Financial Overview
    8.13.4 Recent Developments
    8.14 Lonza
    8.14.1 Company Overview
    8.14.2 Product/Service Landscape
    8.14.3 Financial Overview
    8.14.4 Recent Developments

    The Biotechnology Market has been segmented as below:

    Biotechnology Market, By Application

    • Biopharmacy
    • Bioindustries
    • Bioservices
    • Bioagriculture
    • Bioinformatics

    Biotechnology Market, By Technology

    • Fermentation
    • Tissue engineering and regeneration
    • PCR Technology
    • Nanobiotechnology
    • Chromatography
    • DNA sequencing
    • Cell Based Assay
    • Others

    Biotechnology Market, By Region

    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World

    Biotechnology Market, By Company

    • AstraZeneca
    • Gilead Sciences, Inc.
    • CELGENE CORPORATION
    • Biogen
    • Abbott
    • Amgen Inc.
    • Novo Nordisk A/S
    • Merck & Co.
    • Johnson & Johnson Services, Inc.
    • Novartis AG
    • Sanofi
    • F. Hoffmann-La Roche Ltd.
    • Pfizer, Inc.
    • Lonza

    Got a question? We've got answers. If you have some other questions, see our support center.

    The segment included in Biotechnology Market is Application, Technology, and region.
    Some key players operating in the Biotechnology Market include AstraZeneca, Gilead Sciences, Inc, CELGENE CORPORATION, Biogen, Abbott, Amgen Inc., Novo Nordisk A/S, Merck & Co., Johnson & Johnson Services, Inc
    We can offer several formats of the market research reports including, • PDF • PPT • Spreadsheet/ Workbook

    Related Reports